healthy person
Conditions
Interventions
Duration:4 weeks Test food:Rosemary material Dosage and Administration:Take 5 rosemary capsules twice a day, after breakfast, lunch and dinner.
Sponsors
Clinical Creative Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age:Men and women between 20 and 65 years old (at the time of obtaining consent) who are able to visit the hospital. 2.Healthy subjects (Healthy subjects in this study are defined as those who do not have any serious organ disorder or specific disease, who are not receiving any related treatment, and who are not receiving any medication. Whether or not a person falls under the category of healthy person shall be based on the declaration of the person himself/herself at the start of the study.) 3.Must be able to consume the test food for 4 weeks 4.Those who do not plan to change their daily habits during the examination period. 5.Persons for whom written consent can be obtained 6.Those who do not meet the following exclusion criteria for study participants
Exclusion criteria
Exclusion criteria: 1.Those with a history of treatment for heart failure, myocardial infarction, etc. 2.Exclusion due to disease, etc. (those undergoing treatment for atrial fibrillation, arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, other chronic diseases, etc.) 3.Those who meet the Japanese Society for Medical Checkup criteria D (medical care required). However, this does not apply to those who are judged by the physician to be within the normal error range. 4.Those who regularly use medicines (including herbal medicines)and supplements 5.Those with allergies (to pharmaceuticals and test product-related foods) 6.Pregnant, lactating, or likely to become pregnant during the study period 7.Those who have participated or are currently participating in other clinical trials within one month 8.Any other person who is judged by the principal investigator to be inappropriate for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety assessment of the recommended intake of 1000 mg rosemary material, which is five times the recommended intake of 200 mg rosemary material | — |
Countries
Japan
Contacts
Public ContactKAZUHIRO OHNO
Clinical Creative Co., Ltd. Pharmaceutical Development Division
Outcome results
None listed